Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease

NCT01396603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-03-21

No results posted yet for this study

Summary

This study will evaluate a new imaging technology, termed optical frequency domain imaging (OFDI) for detecting and diagnosing pulmonary malignancy in the central airways.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Melissa J Suter, PhD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2018-01-01
Completion
2018-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01396603 on ClinicalTrials.gov